Starpharma Holdings Limited is an Australian company that specializes in the research, development, and commercialization of dendrimer products for various applications, especially in the pharmaceutical and life sciences industries. The company's main focus is on VivaGel, a microbicidal agent that is currently undergoing Phase III clinical trials for the prevention and management of bacterial vaginosis. The product also has potential as a condom coating for the prevention of sexually transmitted infections.